Genomic Health Inc. (GHDX) Declined -5.52% or -2.88 To Price $49.3 On Wednesday


Genomic Health Inc. (GHDX) declined -5.52% or -2.88 to $49.3. It is about 220552 shares traded, which is 62.68% compare to the average total volume 351886. The market cap of GHDX is $1.74 billion. The year to date change is 45.51%. The 52 week price range is from $26.54 to $53.97. Price of GHDX have changed 0.58% during last week. It have changed 34.76% over last month, 64.55% over last 3 months, 45.51% over last 6 months and 57.45% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GHDX is 40.76. It is -17.32% below current price. The 200-day Moving Averages for GHDX is 34.48. It is -30.06% below current price. The 52-week High is 53.97. It is 9.47% from the current price. The 52-week Low is 26.54. It is -46.17% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GHDX is 3.67 on 2018-05-31. Short % to float is 1.91%. There are some statistics of GHDX. It is has market cap $1.74 billion. The share outstanding is 35.38 million. The average volume is 351886. The revenue is 169.31M. The gross profit is 142.08M. The percent of top 15 Institution holding is 91.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GHDX is -3.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GHDX is -3.07%.


Tags:

Share this post